CCS: Advancing Health Equity Through Cancer Information and Support Services: Report on communities that are underserved

ARCC is pleased to help disseminate the new CCS report  Advancing Health Equity Through Cancer Information and Support Services: Report on communities that are underserved. In 2019, the Canadian Cancer Society carried out the underserved communities project to identify communities that face barriers to accessing cancer information, support and practical (more…)
Canadian Partnership Against Cancer logo

CPAC is Hiring – Lead, Research and Data Partnerships

Position:           Lead, Research and Data Partnerships Reports to:     Manager, Research and Innovation Location: Hybrid. The Partnership’s head office is in downtown Toronto. Candidates can work anywhere in Canada. Job Level: Level 6 salary range: $80,624 – $109,080 per year; Compensation offered will be based on an assessment of the (more…)
Canadian Partnership Against Cancer logo

CPAC is Hiring – Manager, Partner Engagement

Position:           Manager, Parter Engagement Reports to:     Director, Strategy and Partner Experience Location: Hybrid. The Partnership’s head office is in downtown Toronto. Candidates can work anywhere in Canada. Job Level: Level 7 salary range: $100,780 – $138,721 per year; Compensation offered will be based on an assessment of the candidate’s (more…)

Ontario Drug Policy Research Network (ODPRN) Student Training Program – Accepting Applications!

The Ontario Drug Policy Research Network (ODPRN) Student Training Program is now accepting applications to the 2024 Drug Policy Student Training Program, which runs from January 2, 2024 to December 31, 2024. This program aims to engage with students to develop capacity in drug policy research in Ontario. Trainees involved (more…)

Survey: Adolescent and Young Adult (AYA) Cancer Priority Setting Partnership (PSP)

As a partner organization with the AYA Cancer Priority Setting Partnership (PSP), ARCC is happy to promote the launch of the initial national survey ! This is the first step in the James Lind Alliance process to establish the top 10 research priorities for AYA cancer. In this survey, they (more…)

CIHR Travel Awards – Deadline October 11

Through the Institute Community Support (ICS) Program, the CIHR Institutes and Initiatives have opened the fall 2023 ICS Travel Awards competition for students, postdoctoral fellows, early career researchers and knowledge users to present their own research at national and international meetings, workshops, and/or conferences. Deadline: October 11, 2023 For Full (more…)

Executive Director, CAPCA

The Canadian Association of Provincial Cancer Agencies (CAPCA) envisions Canadian cancer control systems that are collaborative, patient-centered, and high performing by international standards. We work to improve cancer control across Canada. Our members are all provincial cancer agencies. Senior cancer program leaders (Chief Executive Officers or designates) from each of the provincial (more…)

Survey: Useful Tools for Cancer Screening/ Sondage: les types d’outils les plus utiles pour le dépistage du cancer

The Canadian Task Force on Preventive Health Care (Task Force) is seeking input from clinicians and members of the public on the types of tools that would be most useful in communicating the Task Force’s guideline recommendations on screening for various cancers. The Knowledge Translation team at St. Michael’s Hospital has developed a survey, (more…)
CIHR logo

CIHR Travel Awards – Institute Community Support

Click here for full details from CIHR These Awards provide travel funds to trainees, Early Career Researchers, or knowledge users in aid of research and knowledge translation activities consistent with the CIHR Initiative’s priorities or CIHR Institutes’ vision, mandate and strategic directions. Each participating Institute/Initiative has their own relevant Research (more…)

Common Sense Oncology

ARCC is pleased to help promote the recent launch of the Common Sense Oncology Movement About Common Sense Oncology Oncology needs a recalibrated approach that is more patient centred and prioritizes equitable cancer care. Our approach prioritizes patients’ needs, advocates for treatments that improve survival and quality-of-life, promotes informed decision (more…)